719 Jadewin Avenue
Richland, WA 99352
United States
206 451 1970
https://www.globestartherapeutics.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. James C. Katzaroff | President, CEO, Secretary, Principal Executive Officer & Chairman of the Board | 180k | N/A | 1957 |
Mr. Robert R. Hale Chicoski CPA | CFO, Treasurer, Secretary, Principal Financial & Accounting Officer | 84k | N/A | 1943 |
Ms. Brooke Greenwald | Chief Marketing Officer | N/A | N/A | N/A |
Mr. David Croom | Executive Vice President | N/A | N/A | N/A |
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in Richland, Washington.
GlobeStar Therapeutics Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.